Skip to main content

Published locations for PREDIX HER2 trial: Similar efficacy, less toxicity with T-DM1 for HER2+, HR+ breast cancer

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. PREDIX HER2 trial: Similar efficacy, less toxicity with T-DM1 for HER2+, HR+ breast cancer

User login

  • Reset your password
  • /content/predix-her2-trial-similar-efficacy-less-toxicity-t-dm1-her2-hr-breast-cancer
  • /oncologypractice/article/202820/breast-cancer/predix-her2-trial-similar-efficacy-less-toxicity-t-dm1
  • /hematology-oncology/article/202820/breast-cancer/predix-her2-trial-similar-efficacy-less-toxicity-t
  • /breast-cancer-icymi/article/202820/breast-cancer/predix-her2-trial-similar-efficacy-less-toxicity-t